Experience Counts For VC Success: HealthCap Hits 25 Year Mark
An Interview With HealthCap Leaders Björn Odlander And Mårten Steen
VC Playbook: The fundamentals do not change in life sciences investing – good science, unmet need and social responsibility.
You may also be interested in...
The Scrip 100 universe gathers FY2021 financial performance data and compares the activities of the top 100 biopharma businesses, ranked by pharma sales.
A selection of articles you might have missed from April 2022, including exclusive interviews, an in depth look at the impact of COVID-19 on clinical trial trends, and the latest Rising Leaders series.
Rising Leader Yolanda Tibbe, Novartis’s head of new commercial partnerships in Germany, talks about transformation at the Swiss big pharma and how to put ‘patients as customers’ thinking into action.